Biochemical analysis of serum pancreatic amylase and lipase enzymes in patients with type 1 and type 2 diabetes mellitus

Saudi Medical Journal

Volumn 26, Issue 1, 2005, Pages 73-77

  Aughsteen, Adib A ^a   Abu Umair, Mustafa S ^a   Mahmoud, Sameer A ^b  

^a AL ZAYTOONAH UNIVERSITY OF JORDAN   (Jordan)

^b Islamic Hospital   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; HEMOGLOBIN A1C; INSULIN; TRIACYLGLYCEROL LIPASE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; ENZYME BLOOD LEVEL; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JORDAN; LABORATORY DIAGNOSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS FUNCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST;

ADULT; AMYLASES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPASE; MALE; MIDDLE AGED;

EID: 14944369940     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Henderson JR, Daniel PM, Fraser PA. The pancreas as a single organ: the influence of the endocrine upon the exocrine part of the gland. Gut 1981; 22: 158-167.
2. Williams PL, Warwick R, Dyson M, Bannister LH. Grays Anatomy, 37th Ed. Edinburgh (UK): Churchill Livingstone; 1989. p. 1380-1384.
3. Korc M, Owerbach D, Quinto C, Rutter WJ. Pancreatic islet-acinar cell interaction: Amylase messenger RNA levels are determined by insulin. Science 1981; 213: 351-353.
4. Adler G, Kern HF. Regulation of exocrine pancreatic secretory process by insulin in vivo. Horm Metab Res 1975; 7: 290-296.
5. Gregoire S, Bendayan M. Immunocytochemical study of pancreatic acinar cells in normal and streptozotocin-induced diabetic rats. Diabetologia 1986; 29: 655-660.
6. Duan RD, Erianson-Albertsson C. Altered synthesis of some secretory proteins in pancreatic lobules isolated from streptozotocin-induced diabetic rats. Pancreas 1990; 5: 136-143.
7. Aughsteen AA, Mohammed FI. Insulin enhances amylase and lipase activity in the pancreas of streptozotocin-diabetic rats. An in vivo study. Saudi Med J 2002; 23: 838-844.
8. Gruddy SM, Benjamin IJ, Bruke GL. Diabetes and cardiovascular disease. A statement for health and professionals from the American Heart Association. Circulation 1999; 100: 1134-1146.
9. Abdel-Gayoum AG. The effect of glycemic control in type 2 diabetic patients with diabetes-related dyslipidemia. Saudi Med J 2004; 25: 207-211.
10. Ali Raza J, Movahed A. Current concepts of cardiovascular diseases in diabetes mellitus. Int J Cardiol 2003; 89: 123-134.
11. Habib SS, Aslam M. Risk factors, knowledge and health status in diabetic patients. Saudi Med J 2003; 24: 1219-1224.
12. Thomas GN, Critchley JA, Tomlinson B, Cockram CS, Chan JC. Peripheral vascular disease in type 2 diabetic Chinese patients: associations with metabolic indices, concomitant vascular disease and genetic factors. Diabet Med 2003; 20: 988-995.
13. Nosadini R, Tonolo G. Relationship between blood glucose control, pathogenesis and progression of diabetic nephropathy. J Am Soc Nephrol 2004; 15 Suppl 1: S1-S5.
14. Hadjadj S, Duly-Bouhanick B, Bekherraz A, BrIdoux F, Gallois Y, Mauco G, et al. Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes. Diabetes Metab 2004; 30: 43-51.
15. Semakula C, Vandewalle CL, Van Schravendijk CF, Sodoyez JC, Schuit FC, Foriers A, et al. Abnormal Circulating pancreatic enzyme activities in more than twenty-five percent of recent-onset insulin-dependent diabetic patients: association of hyperlipasemia with high-titer islet cell antibodies. Belgian Diabetic Registry. Pancreas 1996; 12: 321-333.
16. Lorini R, Cortona L, Scotta MS, Melzi d'Eril GV, Severi F. Exocrine pancreatic function in children and adolescents with insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1990; 8: 263-267.
17. Yajnik CS, Sahasrabudhe RA, Nail SS, Katrak A, Shelgikar KM, Kanitkar SV, et al. Exocrine pancreatic function (serum-immuno reactive trypsin, fecal chymotrypsin, and pancreatic isoamylase in Indian diabetics. Pancreas 1990; 5: 631-638.
18. Kim KH, Lee HS, Kim CD, Chun HJ, Song CW, Um SH, et al. Evaluation of pancreatic exocrine function using pure pancreatic juice in non insulin-dependent diabetes mellitus. J Clin Gastroenterol 2000; 31: 51-54.
19. Kawamori R, Katsura M, Ishida S, Yamasaki Y, Tujii M, Kawano S, et al. Subclinical exocrine pancreatic derangement in human diabetic patients evaluated from pure pancreatic juice. J Diabetes Complications 1995; 9: 69-73.
20. Goda K, Sasaki E, Nagata K, Fukai M, Ohsawa N, Hahafusa T. Pancreatic volume in type 1 and type 2 diabetes mellitus. Acta Diabetol 2001; 38: 145-149.
21. Hardt PD, Hauenschild A, Jaeger C, Teichmann J, Bretzel RG, Kloer HU. High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study. Dig Dis Sci 2003; 48: 1688-1692.
22. Hardt PD, Hauenschild A, Nalop J, Marzeion AM, Jaeger C, Teichmann J, et al. High prevalence of exocrine pancreatic insufficiency in diabetes. A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients. Pancreatology 2003; 3: 395-402.
23. Rathmann W, Haastert B, Icks A, Giani G, Hennings S, Mitchell J, et al. Low fecal elastase 1 concentrations in type 2 diabetes mellitus. Scand J Gastroenterol 2001; 36: 1056-1061.
24. Hardt PD, Krauss A, Bretz L, Porsch-Ozcurumez M, Schnell-Kretschmer H, Maser E, et al. Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitus. Acta Diabetol 2000; 37: 105-110.
25. Nunes AC, Pontes JM, Rosa A, Gomez L, Carvalheiro M, Freitas D. Screening for pancreatic exocrine insufficiency in patients with diabetes mellitus. Am J Gastroenterol 2003; 98: 2672-2675.